Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

C-Rad

32.35 SEK

+3.52 %

Less than 1K followers

CRAD B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+3.52 %
-1.97 %
+1.09 %
-4.99 %
+7.83 %
+9.11 %
-12.45 %
-14.98 %
+149.14 %

C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.

Read more
Market cap
1.09B SEK
Turnover
555.75K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
12.2.
2026

Annual report '25

6.5.
2026

Interim report Q1'26

7.5.
2026

General meeting '26

All
Webcasts
Press releases
3rd party
ShowingAll content types
C-RAD, Audiocast, Q3'25
Webcast10/23/2025, 9:00 AM

C-RAD, Audiocast, Q3'25

C-Rad
Regulatory press release10/22/2025, 3:55 PM

C-RAD has decided to repurchase own class B shares

C-Rad
Regulatory press release10/21/2025, 5:00 PM

C-RAD ABs Interim Report Q3 2025

C-Rad

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Press release10/21/2025, 4:20 PM

C-RAD advances approval of interim report for Q3 2025

C-Rad
Regulatory press release10/21/2025, 4:15 PM

C-RAD's CEO leaves, CFO Linda Frölén appointed acting CEO, Johan Danielsson is appointed deputy CEO

C-Rad
Press release10/9/2025, 6:00 AM

Invitation to presentation of C-RAD’s interim report and report for the third quarter 2025

C-Rad
Press release9/30/2025, 7:00 AM

C-RAD Strengthens Czech Presence with a strategically important order from Krajská Nemocnice Hospital in Liberec.

C-Rad
Press release9/26/2025, 8:00 AM

C-RAD showcases new developments at ASTRO 2025

C-Rad
Regulatory press release7/28/2025, 6:00 AM

C-RAD and iRT Systems announce partnership to advance safety in radiotherapy

C-Rad
C-RAD, Audiocast, Q2'25
Webcast7/18/2025, 9:00 AM

C-RAD, Audiocast, Q2'25

C-Rad
Regulatory press release7/18/2025, 6:00 AM

C-RAD AB's Interim Report Q2 2025

C-Rad
Press release7/4/2025, 7:30 AM

C-RAD Secures 8 MSEK Service Order with Leading U.S. East Coast Healthcare Provider

C-Rad
Press release6/30/2025, 6:00 AM

Invitation to presentation of C-RAD’s interim report and report for the second quarter 2025

C-Rad
Press release6/26/2025, 3:30 PM

C-RAD Expands US Footprint with 10 MSEK Order to Equip Leading Texas Cancer Center with Surface Guided Radiation Therapy Solutions

C-Rad
Press release6/19/2025, 6:00 AM

C-RAD Signs Strategic Agreement with Leading Healthcare Provider in Germany’s Stuttgart Region Valued at 9 MSEK

C-Rad
Press release6/4/2025, 3:30 PM

C-RAD expands footprint in France, by joining forces with leading private healthcare provider Ramsay Santé with high-precision SGRT systems to a total value of 8.5 MSEK

C-Rad
C-RAD, Audiocast with teleconference, Q1'25
Webcast5/7/2025, 9:00 AM

C-RAD, Audiocast with teleconference, Q1'25

C-Rad
Regulatory press release5/7/2025, 6:00 AM

Solid quarter in a wait-and-see market

C-Rad
Regulatory press release5/5/2025, 6:30 PM

C-RAD announces medium-term financial targets

C-Rad
Press release4/30/2025, 9:00 AM

C-RAD Presents New Product Enhancements at ESTRO 2025

C-Rad
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.